Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
作者信息
Smith Philip, Bradley Thomas, Gavarró Lena Morrill, Goranova Teodora, Ennis Darren P, Mirza Hasan B, De Silva Dilrini, Piskorz Anna M, Sauer Carolin M, Al-Khalidi Sarwah, Funingana Ionut-Gabriel, Reinius Marika A V, Giannone Gaia, Lewsley Liz-Anne, Stobo Jamie, McQueen John, Bryson Gareth, Eldridge Matthew, Macintyre Geoff, Markowetz Florian, Brenton James D, McNeish Iain A
机构信息
CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
出版信息
Nat Commun. 2023 Sep 26;14(1):5992. doi: 10.1038/s41467-023-41611-0.
Abstract
摘要
相似文献
1
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.作者更正：复发性卵巢高级别浆液性癌的拷贝数和突变图谱。
Nat Commun. 2023 Sep 26;14(1):5992. doi: 10.1038/s41467-023-41611-0.
2
A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma.BRCA1/2突变特征与高级别浆液性卵巢癌的生存情况
Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1511-1516. doi: 10.1158/1055-9965.EPI-16-0286. Epub 2016 Aug 5.
3
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.高级别浆液性卵巢癌患者具有良好临床预后时的疾病复发以局灶性反复出现的拷贝数改变为特征：一项初步研究。
Genes (Basel). 2019 Sep 5;10(9):678. doi: 10.3390/genes10090678.
4
Amplicon profiles in ovarian serous carcinomas.卵巢浆液性癌中的扩增子图谱。
Int J Cancer. 2007 Jun 15;120(12):2613-7. doi: 10.1002/ijc.22609.
5
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.复发性低级别浆液性卵巢癌对化疗相对耐药。
Gynecol Oncol. 2009 Jul;114(1):48-52. doi: 10.1016/j.ygyno.2009.03.001. Epub 2009 Apr 10.
6
Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous Ovarian Adenocarcinoma.浆液性卵巢腺癌患者肿瘤细胞中某些基因的拷贝数变异特征。
Bull Exp Biol Med. 2021 Jan;170(3):332-339. doi: 10.1007/s10517-021-05062-1. Epub 2021 Jan 16.
7
CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.浆液性输卵管上皮内癌中的CCNE1扩增及中心体数量异常：支持其作为卵巢高级别浆液性癌前驱病变的进一步证据
Mod Pathol. 2016 Oct;29(10):1254-61. doi: 10.1038/modpathol.2016.101. Epub 2016 Jul 22.
8
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.p53 突变模式可区分卵巢浆液性交界性肿瘤以及低级别和高级别癌，并为卵巢癌发生的新模型提供支持：一项免疫组化相关性突变分析
Am J Surg Pathol. 2005 Feb;29(2):218-24. doi: 10.1097/01.pas.0000146025.91953.8d.
9
Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.浆液性癌输卵管前驱病变中的染色体不稳定性以及同步性卵巢和输卵管黏膜浆液性癌的频繁单克隆性。
Gynecol Oncol. 2008 Sep;110(3):408-17. doi: 10.1016/j.ygyno.2008.05.010. Epub 2008 Jul 1.
10
Low-grade Serous Ovarian Carcinoma.低级别浆液性卵巢癌
Geburtshilfe Frauenheilkd. 2018 Oct;78(10):972-976. doi: 10.1055/a-0717-5411. Epub 2018 Oct 19.
引用本文的文献
1
Establishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor.利用来自人类肿瘤的冻存癌细胞建立患者来源的细胞异种移植（PDCX）模型及其效用
Cells. 2025 Feb 21;14(5):325. doi: 10.3390/cells14050325.
2
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.PTEN 缺失重塑高级别浆液性卵巢癌中的巨噬细胞动力学。
Cancer Res. 2024 Nov 15;84(22):3772-3787. doi: 10.1158/0008-5472.CAN-23-3890.
Zotero 插件